A newly aggressive Novo Nordisk is undercutting rival Eli Lilly on the price of its weight loss drugs for cash-paying consumers. Both companies see the direct-to-consumer market as increasingly …
Novo Nordisk, Eli Lilly Weight Loss Price War Heats Up. Why It’s a Worry for the Stocks.
view original post